SPDEF and early-onset autosomal dominant Alzheimer disease: In addition, altered expression of SPDEF has been found in Alzheimer’s disease patients and animal models, while a recent association was found between blood-based Spdef methylation and stress response, altered dopaminergic neurotransmission and increased vulnerability to substance abuse, suggesting its role as a biomarker for these pathological conditions [188,189,190,191].